A transnational pharmaceutical manufacturer producing a wide portfolio of pharmaceutical products and supplements across multiple dosage forms, including injectable and infusion medicines, tablets, capsules and oral powders. It operates several modern production complexes in Eastern Europe, including a large facility with multiple industrial flows built to international standards, and holds national GMP certification for both sterile and non-sterile manufacturing as well as in-house quality control. The company focuses on delivering high-quality, affordable pharmaceutical products in therapeutic areas such as oncology, hormonal therapies, nervous-system disorders, cardiovascular and digestive diseases, pain management and anti-inflammatory care.
Manufacturer usually replies in 2 days
Acetazolamide is a medication used to treat glaucoma, epilepsy, edema, altitude sickness, hydrocephalus, and hypokalemic periodic paralysis. Suppliers of acetazolamide market it in the form of 250mg and 500mg tablets as well as 500mg powders for an injectable solution.
In use for over 50 years, the drug has since become included in the World Health Organization’s List of Essential Medicines that contain the most important drugs recommended for a basic Health System. There are numerous acetazolamide manufacturers and distributors, with the largest globally being companies Teva, TARO, Zydus Pharmaceuticals, and Lannett.
Acetazolamide suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified acetazolamide manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 20 (250mg) tablets of acetazolamide fall into a range of approximately 4,00 EUR to 5,00 EUR.